Kentucky

An RX Fraud Alert has been issued by the Office of Inspector General, Division of Audits & Investigation. The office has seen a huge uptick in prescriber identity theft and forged (C-V) Promethazine with codeine prescriptions across the Commonwealth. They encourage pharmacies to reach out to their Drug Enforcement and Professional Practices Branch with questions, concerns, or fraud reports at 502-564-7985.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

November 12, 2021|Kentucky|

Maryland

The State Health Information Exchange, CRISP (Chesapeake Regional Information System for our Patients) now allows pharmacists access to clinical data for patient treatment and clinical care coordination. It also allows pharmacists to see alerts in the Prescription Drug Monitoring Program (PDMP) like nonfatal overdoses and deceased patient notifications. To access this information, the pharmacy must complete the CRISP Participation Agreement and review additional policies and procedures. For information about the CRISP participation agreement and how to sign, click here. Pharmacies should also contact CRISP outreach at support@crisphealth.org.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

November 12, 2021|Maryland|

New Hampshire

The New Hampshire Board of Pharmacy is proposing to readopt amendment regulations under NHAR Ph 807 and 808 to revise the registered pharmacy technician duties to remove the restriction that a certified pharmacy technician may not perform data entry of prescription medication orders. The rule also would remove the requirement that pharmacy technicians fulfill Pharmacy Technician Certification Board or National Healthcare Association certification. A hearing is scheduled for Nov. 17, 2021, in Concord.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

November 12, 2021|New Hampshire|

New Jersey

The New Jersey Board of Pharmacy is proposing to adopt regulations under NJAC 13:39-1 to require pharmacy permit holders and registered pharmacists-in-charge to implement a continuous quality improvement program to prevent prescription errors.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

November 12, 2021|New Jersey|

Ohio

The Board is proposing an amendment to OAC 4729:5-5-06 to require the contact phone number of the dispensing pharmacy on the prescription label.  This rule only applies to labeling of drugs dispensed by an outpatient pharmacy.  Please send all comments to by close of business November 24th to RuleComments@pharmacy.ohio.gov.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

November 12, 2021|Ohio|

Oklahoma

Board of Pharmacy posted an “Inadequate Staffing” Form on its website.  According to the Board’s notice, a pharmacist may complete this form “if conditions exist that could cause prescriptions to be filled in an unsafe manner with regard to staffing in the pharmacy”.  Board staff will be reviewing the completed forms. 

 Also in Oklahoma, the Board of Pharmacy issued a correction to the OBNDD fax number in this recent communication. The Board of Pharmacy issued this alert: “Please be aware that there have been several Pharmacy Burglaries (Nighttime Break-Ins) recently. Please be alert to any suspicious activities. The DEA 106 Forms for theft/loss of CDS must be reported to the DEA, OBNDD and OSBP. OBNDD is requesting that the pharmacies fax the DEA 106 Forms for Burglaries to: Attention: Cynthia Perez, Criminal Intelligence Analyst, Oklahoma Bureau of Narcotics and Dangerous Drugs – Fax 405-524-7619. Make sure that you include the Police Report and provide Surveillance Video if available. Please make sure that your alarm systems are working properly and consider enhancing your security systems as well.” 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

November 12, 2021|Oklahoma|

Arkansas

Governor Asa Hutchinson (R) and legislative leaders have finally reached an agreement on a tax cut package, so the Governor is now expected to make a formal statement soon announcing that he will convene a special session after Thanksgiving. NACDS has confirmed with several sources that the repeal of the Insulin Rebate law, Act 1104, will be an issue the legislature addresses. 

Also in Arkansas, the Governor has been assured by his Department of Human Services that the federal government will be granting a new waiver soon for the Medicaid expansion program first enacted in 2014.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

November 5, 2021|Arkansas|

California

The Department of Health Care Services published its Medi-Cal Rx Monthly Bulletin – November 1, 2021 issue. Below is the outline from this month’s bulletin 

  1. Changes to the Contract Drugs List (CDL), Effective November 1, 2021 
  2. Changes to the Contract Drugs List (CDL) – Over the Counter Drugs, Effective November 1, 2021 
  3. Pharmacy Provider Notice 
  4. Prior Authorization Fax Form Available 
  5. Medi-Cal Rx Pharmacy Providers Electronic Fund Transfer Set Up and opt out 
  6. Medi-Cal Rx Transition and Resources Training – Register Now! 
  7. Medi-Cal Rx Transition Pharmacy Cutoff Instructions 

Also in California, as of January 1, 2022, all pharmacy benefits will transition away from CA-MMIS and the Medi-Cal managed care plans to Medi-Cal Rx. This transition will create a uniform process for pharmacy providers and prescribers and applies to everyone in Medi-Cal fee-for-service and managed care. All benefits that are billed on a pharmacy claim will be transitioned to Medi-Cal Rx and all Prior Authorizations (PA) will be reviewed by Medi-Cal Rx starting on January 1, 2022. Magellan Rx Management, the state’s vendor, created these resources and information to assist pharmacy providers in their preparations for the implementation of Medi-Cal Rx.  

  • “Are you ready?” – Summary of information and resources for pharmacies and pharmacists. 
  • The Contract Drugs List (CDL) is found on the Medi-Cal Rx Web Portal and contains the searchable Medi-Cal Formulary. The CDL displays drugs covered by Medi-Cal without a prior authorization (PA). The searchable CDL allows prescribers to easily identify all covered drugs. Registering for the Medi-Cal Rx Web Portal allows for easy access to the Provider Portal, where the CDL can be found through the Forms & Information link. 

Also in California, the following documents were recently posted on the Medi-Cal Rx Web Portal: 

Also in California, the Department of Health Care Services (DHCS) is seeking eligible persons to expand the Medi-Cal Contract Drug Advisory Committee to a maximum of ten members, including three pharmacists. Interested persons may submit their statement of qualifications and CV/resume to DHCS by November 19. For details, see “Medi-Cal Contract Drug Advisory Committee (MCDAC)” on the DHCS website 

Also in California, NACDS submitted comments to the Board of Pharmacy outlining concerns with proposed rules that would impose onerous inventory reconciliation requirements on pharmacies throughout the state. Our comments urged the Board not to layer on additional requirements beyond what DEA requires, explaining that the Board’s proposal would result in a cumbersome new process for pharmacies to accommodate.  

Also in California, the Board of Pharmacy published a Notice of Proposed Action that will require each permit holder to notify the board of any temporary closure of a facility as soon as the closure exceeds three consecutive calendar days. The closure status will be public information. Comments on the proposed text will be accepted by the board until December 13. 

Also in California, the Department of Consumer Affairs issued the following waiver extension:  

DCA Waiver DCA-21-200 Order Extending DCA-20-02, 20-57, 20-91, 21-165, and 21-187 Order Waiving License Reactivation or Restoration Requirements – Final Extension. A list of current waivers is available on the DCA website. 

Finally in California, the Department of Public Health developed a Q&A for booster doses now available for Pfizer, Moderna and Johnson & Johnson COVID-19 vaccines. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

November 5, 2021|California|

Delaware

SB 105 which allows pharmacists to administer or dispense hormonal contraceptives under a standing order from the Division of Public Health was signed into law.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

November 5, 2021|Delaware|

District of Columbia

The latest edition of the Board of Pharmacy’s newsletter is available here. It contains updated board contact information, the schedule of meetings, links to the new online licensing portal and a reminder about the Opioid Labeling Act which was effective in March of 2021.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

November 5, 2021|District of Columbia|

Illinois

The Illinois Department of Public Health (IDPH) has issued updated guidance to help people celebrate the holiday season more safely as the state continues to battle the COVID-19 pandemic.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

November 5, 2021|Illinois|

Iowa

The Iowa Department of Public Health (IDPH) posted the following: 

For the latest information and updates impacting Iowa’s enrolled vaccine providers, please visit the IDPH COVID-19 Vaccine Providers webpage, and click on the most recent version of the “ Vaccine Information Brief”. If you have questions, contact the COVID-19 Vaccine Call Center at 1-800-831-6293 ext. 1 or COVID19Vaccine@idph.iowa.gov. 

Also in Iowa, the Board of Pharmacy published a Notice of Intended Action to amend Chapter 39, “Expanded Practice Standards” relating to collaborative pharmacy practice agreements between pharmacists and Iowa-licensed prescribers who have independent prescribing authority. The rule making identifies the minimum required elements of these agreements. Comments are due by 4:30 p.m. on November 23. 

Also in Iowa, the Department of Human Services announced registration is open for the November 2021, December 2021, and January 2022, virtual town halls for both providers and members. Please note the November and December meeting dates are different due to the holidays. Beginning in January 2022, the monthly virtual town halls will be held on the fourth Thursday of each month. For details, including registration, refer to INFORMATIONAL LETTER NO. 2283-MC-FFS-D. 

Finally in Iowa, if you are a provider, or part of a provider entity, that receives payments of $5,000,000 (million) or more from Iowa Medicaid in any federal fiscal year (October 1 to September 30), then INFORMATIONAL LETTER NO. 2275-MC-FFS-D, related to annual submission requirements regarding prevention and detection of Medicaid fraud and abuse, applies to you or your organization.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

November 5, 2021|Iowa|

Missouri

The Department of Commerce and Insurance Department of Health and Senior Services (DHSS) issued a standing order for the Pfizer COVID-19 vaccine for ages 5-11 years old. Pharmacies using a physician protocol to administer the Pfizer COVID-19 pediatric vaccine need to make certain that their protocol includes this age group and booster doses. DHSS will host a webinar on November 8 at 2:00 p.m. Central to discuss booster doses and, vaccinating children ages 5-11 years old. Register at this link.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

November 5, 2021|Missouri|

Nebraska

The Board of Pharmacy published the November 8 meeting agenda and the September 13 draft meeting minutes. The November 8 meeting will be in-person and available to the public via WEBEX; see the agenda for details. 

Also in Nebraska, the Department of Health and Human Services announced the next weekly COVID-19 Medicaid Provider call will take place on November 17 at noon (Central). 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

November 5, 2021|Nebraska|

New York

Governor Kathy Hochul (D) signed into law legislation SB 4807A authorizing pharmacists to administer additional vaccines recommended by the CDC to patients 18 years of age and older. This could not have been achieved without the support and drive of the Community Pharmacy Association of New York State and over 100 patient advocacy groups.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

November 5, 2021|New York|

North Carolina

On October 29, 2021, State Health Director Dr. Betsey Tilson issued new Statewide Standing Orders for Monoclonal Antibody Therapy for COVID-19. 

NC State Health Director’s Statewide Standing Order for Intravenous Administration of Sotrovimab Monoclonal Antibodies, October 29, 2021 

NC State Health Director’s Statewide Standing Order for Intravenous Administration of Bamlanivimab/Etesevimab Monoclonal Antibodies, October 29, 2021 

More information concerning the US DHHS PREP Act declaration authorizing pharmacists to order and administer select COVID-19 therapeutics is found here. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

November 5, 2021|North Carolina|

Oregon

The Board of Pharmacy will conduct its Strategic Planning Meeting on November 17-18 and published an agenda with information for public access by phone. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

November 5, 2021|Oregon|

South Carolina

SCPhA is hosting APhA’s Pharmacy-Based Immunization Delivery Certificate Training Program on January 30, 2022 8:00 a.m. – 5:00 p.m. at 1350 Browning Rd, Columbia, SC 29210. More information can be found here.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

November 5, 2021|South Carolina|

Tennessee

Please see the Provider Notice, which includes updates to the TennCare Preferred Drug List, Clinical Criteria, and Interim Criteria below for November 2021. These changes go into effect on November 1. 

  • BaG removals: Clindesse 
  • Added to non-preferred: Suboxone, Clindesse 
  • Added to preferred: buprenorphine-naloxone film (BESMART only), cinacalcet 
  • Modified criteria/quantity limits for Emflaza, Xeljanz, Xeljanz solution, Xeljanz XR, Olumiant, Rinvoq 

 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

November 5, 2021|Tennessee|

Texas

Having received numerous written comments from Texas pharmacists in advance of the November 2 meeting and hearing from more than a dozen pharmacists, pharmacy technicians and stakeholder groups, the Board voted to withdraw the proposed rules on non-sterile compounding and send back to staff for recommendations on how to proceed.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

November 5, 2021|Texas|
Go to Top